课题基金 / 基金详情

项目摘要

项目成果

Daniel J Campbell的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Immune-mediated autoimmune and inflammatory diseases are a major public health issue. Defining the regulatory mechanisms that normally function to prevent pulmonary inflammation is therefore key to understanding the etiology of these diseases, and for developing therapeutic strategies to boost these activities in patients. Regulatory T cells (TR) expressing the transcription factor Foxp3 play a critical role in preventing autoimmunity and limiting immune-mediated inflammation. We have shown that during type-1 inflammatory responses, Foxp3+ TR upregulate the Th1-specifying transcription factor Tbx21 (T-bet), and that T-bet expression is critical for proper TR homeostasis and function during Th1-mediated inflammation. Therefore, the goals of this proposal are to determine in detail how loss of T-bet specifically within Foxp3+ TR impacts the initiation, progression and termination of Th1 responses in vivo (Specific Aim 1); analyze at the molecular level how Foxp3 and T-bet combine to control the expression of genes involved in Th1/TR differentiation, homeostasis and function (Specific Aim 2); and to identify the cytokines and cellular signals that control the phenotypic and functional differentiation of different TR subsets (Specific Aim 3).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Il-2-mediated immune tolerance
Reprogramming of tissue structural cells by cutaneous CD4+ T cells
Control of CD8+ T cell migration and activation by Flightless-1
Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance
  • 批准号:
    10358624
  • 项目类别:
  • 资助金额:
    $75.42万
  • 财政年份:
    2021
  • 负责人:
    Daniel J Campbell
  • 依托单位:
海外基金